Nektar Therapeutics · NASDAQ:NKTR
Robin Howard W sold 20,000 Nektar Therapeutics shares (Form 4)
Traded Jun 16 to Jun 17, 2026 · Filed Jun 18, 2026
From Jun 16 to Jun 17, 2026, Robin Howard W (Director, President & CEO) sold 20,000 Nektar Therapeutics shares at an average US$60.75 for US$1.22M under a trading plan, leaving 55,045 shares. Filed Jun 18, 2026 (Form 4).
- Sold
- 20,000 shares
- Price
- US$60.75 average (US$59.97 to US$61.65)
- Value
- US$1.22M
- Holding after
- 55,045 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Common Stock | Sale | 5,303 | US$59.97 | 69,742 | Direct |
| Jun 16, 2026 | Common Stock | Sale | 4,697 | US$60.71 | 65,045 | Direct |
| Jun 17, 2026 | Common Stock | Sale | 5,500 | US$60.81 | 59,545 | Direct |
| Jun 17, 2026 | Common Stock | Sale | 4,500 | US$61.65 | 55,045 | Direct |
Source
Related
- Nektar Therapeutics
- Robin Howard W
- Nektar Therapeutics shareholders
- Form 4 · Robin Howard W · Aug 20, 2026
- Form 4 · Robin Howard W · May 21, 2026
- Schedule 13G/A · Two Seas Capital LP · Sep 28, 2026
- Form 4 · Whitfield Roy A · Sep 25, 2026
- Form 4 · Greer R Scott · Sep 25, 2026
- Form 4 · Chess Robert · Sep 25, 2026
- Form 4 · Brainard Diana · Sep 25, 2026